
Five Talking Points for People Skeptical of Psychedelic Therapy
By Jake Sherman It should come as no surprise that many people are skeptical of the use of psychedelics in therapy. For decades, governments made
We’re excited you’re going to join us for the Webinar: Put Your Money Where Your Mind Is: The Psychedelic Investment Landscape on May 6 at 13:00 EST. We’re looking forward to connecting with each other and hearing what Bruce Linton, Jayashree Mitra, and Alex Speiser have to say about investing in psychedelics. The webinar will be moderated by Hayim Raclaw, PsyTech managing director. Add the webinar to your calendar below and until then, stay healthy.
By Jake Sherman It should come as no surprise that many people are skeptical of the use of psychedelics in therapy. For decades, governments made
By Tessa Eskin The past decade has seen numerous clinical trials focused on the medicinal and psychological benefits of psychedelics. The results couldn’t be more
By Brian Lissak For a thorough, in-depth treatment of psychedelics, their history, and their current research and medicinal uses, check out PsyTech’s comprehensive course on the fundamentals
By Jake Sherman Not too long ago, talking in public about the differences between psilocybin and LSD would probably draw some odd looks from people.
By Tessa Eskin The psychedelic renaissance is well underway. Research hubs around the world are conducting clinical trials on the therapeutic and medical benefits of
By Brian Lissak For a thorough, in-depth treatment of psychedelics, their history, and their current research and medicinal uses, check out PsyTech’s comprehensive course on the fundamentals